Contineum Therapeutics, Inc. (CTNM)
8.37
+0.02
(+0.24%)
USD |
NASDAQ |
Oct 22, 10:14
Contineum Therapeutics EPS Diluted (Quarterly) : -0.4044 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4044 |
| March 31, 2026 | -0.3872 |
| December 31, 2025 | -0.4911 |
| September 30, 2025 | -0.455 |
| June 30, 2025 | -0.6194 |
| March 31, 2025 | -0.6181 |
| December 31, 2024 | -0.5633 |
| September 30, 2024 | -0.3989 |
| Date | Value |
|---|---|
| June 30, 2024 | -0.3502 |
| March 31, 2024 | -0.3272 |
| December 31, 2023 | -0.0475 |
| September 30, 2023 | -0.2487 |
| June 30, 2023 | 1.616 |
| March 31, 2023 | -0.1875 |
| December 31, 2022 | -0.2989 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -0.2295 |
| CNBX Pharmaceuticals, Inc. | -0.0001 |
| Arvinas, Inc. | 2.578 |
| Fulcrum Therapeutics, Inc. | -0.3433 |
| Definium Therapeutics, Inc. | -1.436 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.15M |
| Total Expenses (Quarterly) | 15.15M |
| Enterprise Value | 84.09M |
| Earnings Yield | -20.76% |
| Normalized Earnings Yield | -20.76 |